A binding curve can be clean, reproducible and easy to fit while answering a question about the assay surface. Choose a platform that can measure the interaction, then use experimental controls to establish whether the reported rates belong to it. A stronger signal can even make the kinetic interpretation harder.
This comparison uses Cytiva Biacore 8S/8S+ for surface plasmon resonance, Sartorius Octet RH16 for biolayer interferometry, and Malvern Panalytical WAVE/WAVEdelta for grating-coupled interferometry. It covers small-molecule and biologics workflows, with model-specific differences kept explicit. The aim is to select an experimental capability and a convincing demonstration, rather than rank instruments from unrelated manufacturer limits.
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
All three observe binding near an immobilized surface. MEASUREMENT PRINCIPLE | \nSPR detects an optical response near a sensor surface; BLI follows interference changes at a biosensor tip; GCI detects refractive-index changes along a waveguide. Binding accumulates material in the sensing region. | \nSpecific binding, nonspecific adsorption and some solution changes can all contribute. Removing a fluorescent label removes one experimental dependency while retaining surface preparation and reference requirements. | \nBegin with a binding-positive control, a negative analyte and a suitable reference surface. Establish which part of the response is attributable to the intended interaction before choosing a kinetic model. Inspect the reference response before trusting the corrected binding trace. Sources: B1, B4, B6. Mechanistic comparison and proposed controls. | \n
Affinity alone can conceal very different residence times. KINETIC INTERPRETATION | \nFor an ideal one-to-one interaction, KD = koff/kon. In a constructed example, kon = 10⁵ M⁻¹ s⁻¹ and koff = 0.001 s⁻¹ give KD = 10 nM. Increasing both rates tenfold gives the same KD. | \nThe corresponding dissociation half-times are about 693 and 69 seconds. These are simple-model calculations; cellular occupancy also depends on exposure, transport and the biological system. | \nChoose an instrument and protocol able to resolve the rates that distinguish the candidates. Report association and dissociation rates with the affinity when they are identifiable. Equal KD values do not make two compounds interchangeable for a time-dependent biological experiment. Constructed kinetic calculation; no prediction of cellular residence time. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Biacore 8S and 8S+ emphasize parallel flow-based analysis. SPR CONFIGURATION | \nCytiva's May 2026 guide lists 16 flow cells in eight channels for both models. Sample capacity is four 96- or 384-well plates for 8S and twelve for 8S+. The 8S and older 8K generations must retain their own specifications. | \nFlow cells include reference roles; their count is not a count of independently interpretable target interactions. Plate capacity does not determine how many complete concentration series finish in a day. | \nConsider this family for substantial screening and characterization workloads that justify parallel fluidics. Demonstrate the intended referencing scheme, regeneration and control frequency. Ask for completed, accepted kinetic results per day under that method. Sources: B1. PDF p 4; manufacturer configuration data. | \n
Octet RH16 measures up to sixteen biosensors in parallel. BLI CONFIGURATION | \nThe RH16 datasheet lists 16 spectrometers, up to 16 simultaneous reads and two plate positions. Supported formats include standard 96- and 384-well plates and the specified 384 tilted-well plate. | \nSensors, reference wells and concentration-series design determine usable experimental parallelism. A full set of probes does not necessarily represent sixteen different compounds with complete kinetic characterization. | \nBLI is attractive when a dip-and-read workflow fits the sample set, including protein screening and characterization. Map the entire experiment onto sensors and wells before estimating throughput. Reserve capacity for blanks, controls and failed or unsuitable surfaces. Sources: B3. PDF p 4; manufacturer configuration data. | \n
WAVE and WAVEdelta differ in more than their names. GCI CONFIGURATION | \nThe brochure lists two parallel flow paths for WAVE and four for WAVEdelta. WAVEdelta adds flexible channel referencing, switching among four buffers and waveRAPID functionality; the listed WAVE model does not provide waveRAPID. | \nA result produced with one configuration should not be used to promise the other's throughput or method options. Reference allocation further reduces the number of simultaneous target measurements. | \nFor a GCI demonstration, specify the actual model, fluidic arrangement, software and method. Compare conventional concentration-series kinetics with the accelerated method where available, using the same target and a representative set of analytes. Sources: B6. PDF p 7, printed pp 12–13; model-specific features. | \n
Required sample volume and consumed sample are different quantities. MATERIAL BUDGET | \nRH16 lists 40–100 µL per well in its tilted-well format, 80–130 µL in standard 384-well plates and 180–220 µL in 96-well plates. Biacore 8S lists injection volume plus an application-dependent 20–50 µL. | \nA BLI well may permit sample recovery, but recovered material has experienced contact and incubation. Flow-based sample requirements include access volume beyond the liquid injected over the surface. | \nBudget the mass needed for the complete concentration series, references, replicates and repeat runs. Specify what can genuinely be recovered and reused. Small disposable sensors and small sensor chambers do not by themselves establish low total sample consumption. Sources: B3, B1. Manufacturer volumes; practical material accounting. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Stable temperature is part of the kinetic experiment. THERMAL CONTROL | \nBiacore 8S lists 4–40°C under its stated ambient conditions; RH16 specifies ambient plus 4°C to 40°C. WAVE lists 15–40°C and WAVEdelta 4–45°C, with a maximum 15°C depression below ambient for WAVEdelta. | \nThe room-temperature label does not establish a common measurement temperature. If a laboratory is 24°C, an ambient-plus-4°C lower limit corresponds to 28°C. Sample storage temperature is another setting. | \nChoose a temperature supported by all systems in a cross-platform study, then equilibrate buffers, samples and surfaces. If the scientific question requires a temperature one configuration cannot hold, treat that as a real selection constraint. Use a temperature appropriate to the interaction and hold it reproducibly. Sources: B1, B2, B6. Conditional specifications and arithmetic example. | \n
A faster optical readout does not establish faster resolvable kinetics. TIME RESOLUTION | \nAssociation and dissociation are observed after sample delivery changes the local analyte concentration. Fluid exchange, dispersion and the instrument's acquisition interval all contribute to the observed transition. | \nA nominal sampling frequency can be much faster than the effective concentration step. Fitting an interaction that disappears largely during the transition can produce a precise-looking but poorly constrained rate. | \nChallenge the intended fast-rate regime using a suitable reference interaction. Inspect the injection transition and residuals, not only the fitted parameter. Require the vendor to explain the validated rate range for that molecular class, surface and acquisition method. Sources: B4, B7. Mechanistic inference and proposed time-response test. | \n
Accelerated methods change the experimental design. WAVERAPID | \nThe manufacturer describes waveRAPID as repeated analyte pulses of increasing duration at one concentration. Its hit-discovery study compares this approach with conventional kinetic measurements for the tested compounds. | \nOne concentration reduces preparation work but retains dependence on concentration accuracy, model suitability and enough information in the pulse response. Results from the published set do not establish universal equivalence. | \nUse it for a representative screening challenge, then confirm important or unusual hits with a concentration series and appropriate controls. Retain the raw response and method settings. Faster triage has value when its errors are understood and consequential hits receive suitable follow-up. Sources: B7. Manufacturer study and proposed confirmation strategy. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Small molecules demand an honest signal budget. FRAGMENT AND COMPOUND WORK | \nSartorius provides a small-molecule kinetics protocol for appropriate Octet configurations. Such measurements require deliberate target loading, controls and assay optimization; BLI is not categorically restricted to large analytes. | \nLow molecular mass produces a small binding response relative to the immobilized target. Raising surface loading can increase response while worsening surface-related artifacts. Solubility and stock solvent can constrain attainable concentrations. | \nBring representative low-mass compounds, weak binders and negatives to the demonstration. Ask for acceptable kinetic results at realistic concentrations. Avoid selecting from a molecular-weight limit alone, or extrapolating an antibody demonstration to a fragment campaign. Sources: B5. Application-specific capability and proposed test. | \n
Surface density is an experimental variable. IMMOBILIZATION | \nZhao and colleagues compared SPR surface chemistries, loading densities and capture strategies in an antibody–antigen model. Their study examines changes in activity and heterogeneity as well as fitted binding parameters. | \nMore immobilized protein can create a larger signal without preserving the same accessible population. Coupling orientation or local crowding can change which sites the analyte encounters. | \nPrepare at least two useful surface densities, and consider another capture orientation for consequential results. Seek rates that remain reasonably consistent when the experiment is changed in ways that should preserve the molecular interaction. Treat reproducibility on one surface as incomplete evidence. Sources: B9. Primary study; proposed discrimination test. | \n
Transport and rebinding can imitate slow molecular behavior. KINETIC ARTIFACTS | \nSartorius' kinetics guide discusses transport-limited association and analyte rebinding. Delivery to a crowded surface can limit observed association; dissociated analyte can encounter another nearby binding site. | \nIncreasing flow or agitation and reducing ligand loading may change these effects, but the intervention must remain compatible with the assay. Adding fit parameters alone does not identify the correct mechanism. | \nCompare reasonable flow or agitation settings and loading densities. Inspect whether the derived rates move systematically. If they do, investigate transport and surface behavior before interpreting an unusually slow dissociation as a desirable compound property. Sources: B4. Mechanistic guidance and proposed controls. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Avidity can make a multivalent analyte look exceptionally tight. BIOLOGICS | \nThe Octet avidity guidance identifies assay orientation, valency, ligand density and nonspecific binding as important design variables. A multivalent analyte may maintain attachment through more than one interaction. | \nAn apparent slow off-rate can describe that multivalent configuration rather than a single binding site's intrinsic affinity. A one-to-one fit may conceal the distinction while producing attractive numbers. | \nUse a monovalent reagent or reverse the orientation when feasible, and vary surface density. Decide whether the program needs intrinsic affinity or functional avidity in a defined geometry. Both can be useful, provided the reported quantity matches the experiment. Sources: B8. Manufacturer assay-design guidance and interpretation. | \n
Solvent and matrix effects deserve their own references. BACKGROUND RESPONSE | \nThe Octet small-molecule note addresses preparation and control of DMSO-containing measurements. Surface-based optical signals can also respond to nonspecific material and differences between sample and running buffer. | \nSubtracting a reference can remove shared response while leaving mismatches between surfaces. A target-free surface may not reproduce the nonspecific binding of a protein-coated surface. | \nMatch solvent composition, inspect blanks across the concentration range and use the platform's validated referencing or solvent-correction procedure. Examine unprocessed curves alongside corrected data. A correction that leaves a tidy curve has not, by itself, established target-specific binding. Sources: B5. Source-supported controls; interpretation applies within the chosen platform method. | \n
Very slow dissociation needs enough time to be observed. IDENTIFIABILITY | \nFor a constructed first-order koff of 10⁻⁶ s⁻¹, the half-time is about eight days. During a ten-minute dissociation interval, the ideal signal falls by only 0.060%. | \nDrift, regeneration effects and surface stability can overwhelm that small change. A lower advertised rate limit does not mean every short run can determine a rate at that limit. | \nDesign observation time around the change that must be distinguished from baseline behavior. Report a bound or an unresolved slow rate when the data do not identify a precise value. Avoid turning a flat trace into an exact residence-time claim. Constructed exponential-decay calculation. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Parallel BLI can simplify protein screening logistics. WORKFLOW FIT | \nThe RH16's parallel probe format and plate handling can suit repeated measurements across protein samples. Sample contact occurs at disposable biosensor tips rather than requiring every sample to traverse a shared sensing flow cell. | \nSensor preparation, well volume, incubation time and reference allocation still consume capacity. Matrix tolerance must be shown for the actual samples and detection surface. | \nFavor this approach when the plate-based preparation and analysis workflow match the program. Demonstrate crude and purified samples separately. Include the cost of sensor loading and repeat measurements when comparing it with flow-based methods. Sources: B3. Configuration-based recommendation; no universal superiority claim. | \n
Flow control can support discriminating kinetic experiments. WORKFLOW FIT | \nBiacore and WAVEsystem configurations provide controlled fluid delivery over sensor surfaces. Changing delivery conditions can help probe whether observed behavior is limited by transport or by the interaction itself. | \nFlow paths require suitable samples, cleaning and carryover control. A disposable sensing cartridge can simplify part of that handling while leaving autosampler and upstream sample-contact components to consider. | \nFavor a flow-based approach when the question benefits from defined injections, rapid buffer changes or delivery-rate challenges. Use a difficult but realistic sample sequence to assess carryover, recovery and maintenance time. Evaluate data quality after that challenge, not just during a clean reference run. | \n
Independent methods can expose a shared-looking result. ORTHOGONAL CONFIRMATION | \nA solution-phase binding or functional assay can ask a different question from a surface measurement. Agreement is particularly useful when the experimental dependencies are genuinely different. | \nChanging the optical detector while retaining the same construct, capture reagent and immobilization geometry may preserve the dominant artifact. Disagreement can also arise from temperature, valency or buffer changes rather than instrument failure. | \nFor important candidates, document what changed between methods. Reconcile differences by testing the most plausible cause. Choose confirmation experiments that distinguish the competing explanations. Another KD becomes useful when its experimental dependencies are understood. Proposed confirmation strategy. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Request the raw curves and a challenge set. DEMONSTRATION | \nProvide a reference binder, a negative, a weak binder, a fast interaction and a sample with realistic matrix complexity. Predefine the concentrations, observation periods and referencing rules before comparing systems. | \nA vendor's best example leaves the success rate for a mixed discovery sample set unresolved. Retain failed fits and low-response samples in that denominator. | \nCount accepted results, unresolved rates, repeats and material used. Review residuals, reference traces and fit exclusions with the vendor. Keep temperature and biological materials aligned where possible, and explicitly record unavoidable differences between methods. Proposed benchmark; no physical cross-platform test performed. | \n
Buy the supported method as well as the instrument. CORE LAB AND PROGRAM FIT | \nThe operating cost includes sensor consumables, coupling reagents, sample preparation, cleaning, analysis software, staff training and time spent resolving difficult curves. Prices and support packages require current quotations. | \nAn instrument may cover many applications in principle while local expertise supports only a few robustly. Automated fitting can reduce routine work without replacing someone who recognizes a failed model. | \nFor a core facility, assess changeover and training across targets. For a screening program, assess accepted results from the recurring method. Include a written acceptance experiment and access to raw data in the purchasing discussion. Procurement and staffing recommendation. | \n
Manufacturer specifications describe the named product and configuration; they are not independent all-vendor benchmarks. Row-level source IDs link to the references below. Calculations and practical interpretations are identified separately. No physical comparison or procurement quotation is represented by these tables.
B1 Cytiva Biacore selection guide May 2026
B4 Octet binding kinetics application note
B5 Octet small molecule binding kinetics
B7 waveRAPID hit discovery study
B9 Zhao et al 2013 — A comparison of binding surfaces for SPR biosensing, abstract and figure captions
", "body_text": "A binding curve can be clean, reproducible and easy to fit while answering a question about the assay surface. Choose a platform that can measure the interaction, then use experimental controls to establish whether the reported rates belong to it. A stronger signal can even make the kinetic interpretation harder.\n\nThis comparison uses Cytiva Biacore 8S/8S+ for surface plasmon resonance, Sartorius Octet RH16 for biolayer interferometry, and Malvern Panalytical WAVE/WAVEdelta for grating-coupled interferometry. It covers small-molecule and biologics workflows, with model-specific differences kept explicit. The aim is to select an experimental capability and a convincing demonstration, rather than rank instruments from unrelated manufacturer limits.\n\nHeadlinesLabel free binding instruments for drug discovery — HeadlinesThe finding | Technology and product evidence | Trade-offs and controls | What it means | \n\nAll three observe binding near an immobilized surface.MEASUREMENT PRINCIPLE | \nSPR detects an optical response near a sensor surface; BLI follows interference changes at a biosensor tip; GCI detects refractive-index changes along a waveguide. Binding accumulates material in the sensing region. | \nSpecific binding, nonspecific adsorption and some solution changes can all contribute. Removing a fluorescent label removes one experimental dependency while retaining surface preparation and reference requirements. | \nBegin with a binding-positive control, a negative analyte and a suitable reference surface. Establish which part of the response is attributable to the intended interaction before choosing a kinetic model. Inspect the reference response before trusting the corrected binding trace.Sources: B1, B4, B6. Mechanistic comparison and proposed controls. | \n\n\nAffinity alone can conceal very different residence times.KINETIC INTERPRETATION | \nFor an ideal one-to-one interaction, KD = koff/kon. In a constructed example, kon = 10⁵ M⁻¹ s⁻¹ and koff = 0.001 s⁻¹ give KD = 10 nM. Increasing both rates tenfold gives the same KD. | \nThe corresponding dissociation half-times are about 693 and 69 seconds. These are simple-model calculations; cellular occupancy also depends on exposure, transport and the biological system. | \nChoose an instrument and protocol able to resolve the rates that distinguish the candidates. Report association and dissociation rates with the affinity when they are identifiable. Equal KD values do not make two compounds interchangeable for a time-dependent biological experiment.Constructed kinetic calculation; no prediction of cellular residence time. | \n\n\n\nSpecificationsLabel free binding instruments for drug discovery — SpecificationsThe finding | Technology and product evidence | Trade-offs and controls | What it means | \n\nBiacore 8S and 8S+ emphasize parallel flow-based analysis.SPR CONFIGURATION | \nCytiva's May 2026 guide lists 16 flow cells in eight channels for both models. Sample capacity is four 96- or 384-well plates for 8S and twelve for 8S+. The 8S and older 8K generations must retain their own specifications. | \nFlow cells include reference roles; their count is not a count of independently interpretable target interactions. Plate capacity does not determine how many complete concentration series finish in a day. | \nConsider this family for substantial screening and characterization workloads that justify parallel fluidics. Demonstrate the intended referencing scheme, regeneration and control frequency. Ask for completed, accepted kinetic results per day under that method.Sources: B1. PDF p 4; manufacturer configuration data. | \n\n\nOctet RH16 measures up to sixteen biosensors in parallel.BLI CONFIGURATION | \nThe RH16 datasheet lists 16 spectrometers, up to 16 simultaneous reads and two plate positions. Supported formats include standard 96- and 384-well plates and the specified 384 tilted-well plate. | \nSensors, reference wells and concentration-series design determine usable experimental parallelism. A full set of probes does not necessarily represent sixteen different compounds with complete kinetic characterization. | \nBLI is attractive when a dip-and-read workflow fits the sample set, including protein screening and characterization. Map the entire experiment onto sensors and wells before estimating throughput. Reserve capacity for blanks, controls and failed or unsuitable surfaces.Sources: B3. PDF p 4; manufacturer configuration data. | \n\n\nWAVE and WAVEdelta differ in more than their names.GCI CONFIGURATION | \nThe brochure lists two parallel flow paths for WAVE and four for WAVEdelta. WAVEdelta adds flexible channel referencing, switching among four buffers and waveRAPID functionality; the listed WAVE model does not provide waveRAPID. | \nA result produced with one configuration should not be used to promise the other's throughput or method options. Reference allocation further reduces the number of simultaneous target measurements. | \nFor a GCI demonstration, specify the actual model, fluidic arrangement, software and method. Compare conventional concentration-series kinetics with the accelerated method where available, using the same target and a representative set of analytes.Sources: B6. PDF p 7, printed pp 12–13; model-specific features. | \n\n\nRequired sample volume and consumed sample are different quantities.MATERIAL BUDGET | \nRH16 lists 40–100 µL per well in its tilted-well format, 80–130 µL in standard 384-well plates and 180–220 µL in 96-well plates. Biacore 8S lists injection volume plus an application-dependent 20–50 µL. | \nA BLI well may permit sample recovery, but recovered material has experienced contact and incubation. Flow-based sample requirements include access volume beyond the liquid injected over the surface. | \nBudget the mass needed for the complete concentration series, references, replicates and repeat runs. Specify what can genuinely be recovered and reused. Small disposable sensors and small sensor chambers do not by themselves establish low total sample consumption.Sources: B3, B1. Manufacturer volumes; practical material accounting. | \n\n\n\nFeaturesLabel free binding instruments for drug discovery — FeaturesThe finding | Technology and product evidence | Trade-offs and controls | What it means | \n\nStable temperature is part of the kinetic experiment.THERMAL CONTROL | \nBiacore 8S lists 4–40°C under its stated ambient conditions; RH16 specifies ambient plus 4°C to 40°C. WAVE lists 15–40°C and WAVEdelta 4–45°C, with a maximum 15°C depression below ambient for WAVEdelta. | \nThe room-temperature label does not establish a common measurement temperature. If a laboratory is 24°C, an ambient-plus-4°C lower limit corresponds to 28°C. Sample storage temperature is another setting. | \nChoose a temperature supported by all systems in a cross-platform study, then equilibrate buffers, samples and surfaces. If the scientific question requires a temperature one configuration cannot hold, treat that as a real selection constraint. Use a temperature appropriate to the interaction and hold it reproducibly.Sources: B1, B2, B6. Conditional specifications and arithmetic example. | \n\n\nA faster optical readout does not establish faster resolvable kinetics.TIME RESOLUTION | \nAssociation and dissociation are observed after sample delivery changes the local analyte concentration. Fluid exchange, dispersion and the instrument's acquisition interval all contribute to the observed transition. | \nA nominal sampling frequency can be much faster than the effective concentration step. Fitting an interaction that disappears largely during the transition can produce a precise-looking but poorly constrained rate. | \nChallenge the intended fast-rate regime using a suitable reference interaction. Inspect the injection transition and residuals, not only the fitted parameter. Require the vendor to explain the validated rate range for that molecular class, surface and acquisition method.Sources: B4, B7. Mechanistic inference and proposed time-response test. | \n\n\nAccelerated methods change the experimental design.WAVERAPID | \nThe manufacturer describes waveRAPID as repeated analyte pulses of increasing duration at one concentration. Its hit-discovery study compares this approach with conventional kinetic measurements for the tested compounds. | \nOne concentration reduces preparation work but retains dependence on concentration accuracy, model suitability and enough information in the pulse response. Results from the published set do not establish universal equivalence. | \nUse it for a representative screening challenge, then confirm important or unusual hits with a concentration series and appropriate controls. Retain the raw response and method settings. Faster triage has value when its errors are understood and consequential hits receive suitable follow-up.Sources: B7. Manufacturer study and proposed confirmation strategy. | \n\n\n\nCapabilitiesLabel free binding instruments for drug discovery — CapabilitiesThe finding | Technology and product evidence | Trade-offs and controls | What it means | \n\nSmall molecules demand an honest signal budget.FRAGMENT AND COMPOUND WORK | \nSartorius provides a small-molecule kinetics protocol for appropriate Octet configurations. Such measurements require deliberate target loading, controls and assay optimization; BLI is not categorically restricted to large analytes. | \nLow molecular mass produces a small binding response relative to the immobilized target. Raising surface loading can increase response while worsening surface-related artifacts. Solubility and stock solvent can constrain attainable concentrations. | \nBring representative low-mass compounds, weak binders and negatives to the demonstration. Ask for acceptable kinetic results at realistic concentrations. Avoid selecting from a molecular-weight limit alone, or extrapolating an antibody demonstration to a fragment campaign.Sources: B5. Application-specific capability and proposed test. | \n\n\nSurface density is an experimental variable.IMMOBILIZATION | \nZhao and colleagues compared SPR surface chemistries, loading densities and capture strategies in an antibody–antigen model. Their study examines changes in activity and heterogeneity as well as fitted binding parameters. | \nMore immobilized protein can create a larger signal without preserving the same accessible population. Coupling orientation or local crowding can change which sites the analyte encounters. | \nPrepare at least two useful surface densities, and consider another capture orientation for consequential results. Seek rates that remain reasonably consistent when the experiment is changed in ways that should preserve the molecular interaction. Treat reproducibility on one surface as incomplete evidence.Sources: B9. Primary study; proposed discrimination test. | \n\n\nTransport and rebinding can imitate slow molecular behavior.KINETIC ARTIFACTS | \nSartorius' kinetics guide discusses transport-limited association and analyte rebinding. Delivery to a crowded surface can limit observed association; dissociated analyte can encounter another nearby binding site. | \nIncreasing flow or agitation and reducing ligand loading may change these effects, but the intervention must remain compatible with the assay. Adding fit parameters alone does not identify the correct mechanism. | \nCompare reasonable flow or agitation settings and loading densities. Inspect whether the derived rates move systematically. If they do, investigate transport and surface behavior before interpreting an unusually slow dissociation as a desirable compound property.Sources: B4. Mechanistic guidance and proposed controls. | \n\n\n\nDownsidesLabel free binding instruments for drug discovery — DownsidesThe finding | Technology and product evidence | Trade-offs and controls | What it means | \n\nAvidity can make a multivalent analyte look exceptionally tight.BIOLOGICS | \nThe Octet avidity guidance identifies assay orientation, valency, ligand density and nonspecific binding as important design variables. A multivalent analyte may maintain attachment through more than one interaction. | \nAn apparent slow off-rate can describe that multivalent configuration rather than a single binding site's intrinsic affinity. A one-to-one fit may conceal the distinction while producing attractive numbers. | \nUse a monovalent reagent or reverse the orientation when feasible, and vary surface density. Decide whether the program needs intrinsic affinity or functional avidity in a defined geometry. Both can be useful, provided the reported quantity matches the experiment.Sources: B8. Manufacturer assay-design guidance and interpretation. | \n\n\nSolvent and matrix effects deserve their own references.BACKGROUND RESPONSE | \nThe Octet small-molecule note addresses preparation and control of DMSO-containing measurements. Surface-based optical signals can also respond to nonspecific material and differences between sample and running buffer. | \nSubtracting a reference can remove shared response while leaving mismatches between surfaces. A target-free surface may not reproduce the nonspecific binding of a protein-coated surface. | \nMatch solvent composition, inspect blanks across the concentration range and use the platform's validated referencing or solvent-correction procedure. Examine unprocessed curves alongside corrected data. A correction that leaves a tidy curve has not, by itself, established target-specific binding.Sources: B5. Source-supported controls; interpretation applies within the chosen platform method. | \n\n\nVery slow dissociation needs enough time to be observed.IDENTIFIABILITY | \nFor a constructed first-order koff of 10⁻⁶ s⁻¹, the half-time is about eight days. During a ten-minute dissociation interval, the ideal signal falls by only 0.060%. | \nDrift, regeneration effects and surface stability can overwhelm that small change. A lower advertised rate limit does not mean every short run can determine a rate at that limit. | \nDesign observation time around the change that must be distinguished from baseline behavior. Report a bound or an unresolved slow rate when the data do not identify a precise value. Avoid turning a flat trace into an exact residence-time claim.Constructed exponential-decay calculation. | \n\n\n\nAdvantagesLabel free binding instruments for drug discovery — AdvantagesThe finding | Technology and product evidence | Trade-offs and controls | What it means | \n\nParallel BLI can simplify protein screening logistics.WORKFLOW FIT | \nThe RH16's parallel probe format and plate handling can suit repeated measurements across protein samples. Sample contact occurs at disposable biosensor tips rather than requiring every sample to traverse a shared sensing flow cell. | \nSensor preparation, well volume, incubation time and reference allocation still consume capacity. Matrix tolerance must be shown for the actual samples and detection surface. | \nFavor this approach when the plate-based preparation and analysis workflow match the program. Demonstrate crude and purified samples separately. Include the cost of sensor loading and repeat measurements when comparing it with flow-based methods.Sources: B3. Configuration-based recommendation; no universal superiority claim. | \n\n\nFlow control can support discriminating kinetic experiments.WORKFLOW FIT | \nBiacore and WAVEsystem configurations provide controlled fluid delivery over sensor surfaces. Changing delivery conditions can help probe whether observed behavior is limited by transport or by the interaction itself. | \nFlow paths require suitable samples, cleaning and carryover control. A disposable sensing cartridge can simplify part of that handling while leaving autosampler and upstream sample-contact components to consider. | \nFavor a flow-based approach when the question benefits from defined injections, rapid buffer changes or delivery-rate challenges. Use a difficult but realistic sample sequence to assess carryover, recovery and maintenance time. Evaluate data quality after that challenge, not just during a clean reference run.Sources: B1, B6. Mechanistic and workflow inference. | \n\n\nIndependent methods can expose a shared-looking result.ORTHOGONAL CONFIRMATION | \nA solution-phase binding or functional assay can ask a different question from a surface measurement. Agreement is particularly useful when the experimental dependencies are genuinely different. | \nChanging the optical detector while retaining the same construct, capture reagent and immobilization geometry may preserve the dominant artifact. Disagreement can also arise from temperature, valency or buffer changes rather than instrument failure. | \nFor important candidates, document what changed between methods. Reconcile differences by testing the most plausible cause. Choose confirmation experiments that distinguish the competing explanations. Another KD becomes useful when its experimental dependencies are understood.Proposed confirmation strategy. | \n\n\n\nNotable DetailsLabel free binding instruments for drug discovery — Notable DetailsThe finding | Technology and product evidence | Trade-offs and controls | What it means | \n\nRequest the raw curves and a challenge set.DEMONSTRATION | \nProvide a reference binder, a negative, a weak binder, a fast interaction and a sample with realistic matrix complexity. Predefine the concentrations, observation periods and referencing rules before comparing systems. | \nA vendor's best example leaves the success rate for a mixed discovery sample set unresolved. Retain failed fits and low-response samples in that denominator. | \nCount accepted results, unresolved rates, repeats and material used. Review residuals, reference traces and fit exclusions with the vendor. Keep temperature and biological materials aligned where possible, and explicitly record unavoidable differences between methods.Proposed benchmark; no physical cross-platform test performed. | \n\n\nBuy the supported method as well as the instrument.CORE LAB AND PROGRAM FIT | \nThe operating cost includes sensor consumables, coupling reagents, sample preparation, cleaning, analysis software, staff training and time spent resolving difficult curves. Prices and support packages require current quotations. | \nAn instrument may cover many applications in principle while local expertise supports only a few robustly. Automated fitting can reduce routine work without replacing someone who recognizes a failed model. | \nFor a core facility, assess changeover and training across targets. For a screening program, assess accepted results from the recurring method. Include a written acceptance experiment and access to raw data in the purchasing discussion.Procurement and staffing recommendation. | \n\n\n\nAbout the sources\n\nManufacturer specifications describe the named product and configuration; they are not independent all-vendor benchmarks. Row-level source IDs link to the references below. Calculations and practical interpretations are identified separately. No physical comparison or procurement quotation is represented by these tables.\n\nB1 Cytiva Biacore selection guide May 2026\n\nB2 Octet RH16 specifications\n\nB3 Octet RH16 datasheet\n\nB4 Octet binding kinetics application note\n\nB5 Octet small molecule binding kinetics\n\nB6 WAVEsystem brochure\n\nB7 waveRAPID hit discovery study\n\nB8 Octet avoiding avidity\n\nB9 Zhao et al 2013 — A comparison of binding surfaces for SPR biosensing, abstract and figure captions", "sections": [ { "id": "introduction", "heading": "Introduction", "blocks": [ { "type": "p", "text": "A binding curve can be clean, reproducible and easy to fit while answering a question about the assay surface. Choose a platform that can measure the interaction, then use experimental controls to establish whether the reported rates belong to it. A stronger signal can even make the kinetic interpretation harder.", "html": "A binding curve can be clean, reproducible and easy to fit while answering a question about the assay surface. Choose a platform that can measure the interaction, then use experimental controls to establish whether the reported rates belong to it. A stronger signal can even make the kinetic interpretation harder.
" }, { "type": "p", "text": "This comparison uses Cytiva Biacore 8S/8S+ for surface plasmon resonance, Sartorius Octet RH16 for biolayer interferometry, and Malvern Panalytical WAVE/WAVEdelta for grating-coupled interferometry. It covers small-molecule and biologics workflows, with model-specific differences kept explicit. The aim is to select an experimental capability and a convincing demonstration, rather than rank instruments from unrelated manufacturer limits.", "html": "This comparison uses Cytiva Biacore 8S/8S+ for surface plasmon resonance, Sartorius Octet RH16 for biolayer interferometry, and Malvern Panalytical WAVE/WAVEdelta for grating-coupled interferometry. It covers small-molecule and biologics workflows, with model-specific differences kept explicit. The aim is to select an experimental capability and a convincing demonstration, rather than rank instruments from unrelated manufacturer limits.
" }, { "type": "section", "text": "HeadlinesLabel free binding instruments for drug discovery — HeadlinesThe finding | Technology and product evidence | Trade-offs and controls | What it means | \n\nAll three observe binding near an immobilized surface.MEASUREMENT PRINCIPLE | \nSPR detects an optical response near a sensor surface; BLI follows interference changes at a biosensor tip; GCI detects refractive-index changes along a waveguide. Binding accumulates material in the sensing region. | \nSpecific binding, nonspecific adsorption and some solution changes can all contribute. Removing a fluorescent label removes one experimental dependency while retaining surface preparation and reference requirements. | \nBegin with a binding-positive control, a negative analyte and a suitable reference surface. Establish which part of the response is attributable to the intended interaction before choosing a kinetic model. Inspect the reference response before trusting the corrected binding trace.Sources: B1, B4, B6. Mechanistic comparison and proposed controls. | \n\n\nAffinity alone can conceal very different residence times.KINETIC INTERPRETATION | \nFor an ideal one-to-one interaction, KD = koff/kon. In a constructed example, kon = 10⁵ M⁻¹ s⁻¹ and koff = 0.001 s⁻¹ give KD = 10 nM. Increasing both rates tenfold gives the same KD. | \nThe corresponding dissociation half-times are about 693 and 69 seconds. These are simple-model calculations; cellular occupancy also depends on exposure, transport and the biological system. | \nChoose an instrument and protocol able to resolve the rates that distinguish the candidates. Report association and dissociation rates with the affinity when they are identifiable. Equal KD values do not make two compounds interchangeable for a time-dependent biological experiment.Constructed kinetic calculation; no prediction of cellular residence time. | \n\n", "html": "| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
All three observe binding near an immobilized surface. MEASUREMENT PRINCIPLE | \nSPR detects an optical response near a sensor surface; BLI follows interference changes at a biosensor tip; GCI detects refractive-index changes along a waveguide. Binding accumulates material in the sensing region. | \nSpecific binding, nonspecific adsorption and some solution changes can all contribute. Removing a fluorescent label removes one experimental dependency while retaining surface preparation and reference requirements. | \nBegin with a binding-positive control, a negative analyte and a suitable reference surface. Establish which part of the response is attributable to the intended interaction before choosing a kinetic model. Inspect the reference response before trusting the corrected binding trace. Sources: B1, B4, B6. Mechanistic comparison and proposed controls. | \n
Affinity alone can conceal very different residence times. KINETIC INTERPRETATION | \nFor an ideal one-to-one interaction, KD = koff/kon. In a constructed example, kon = 10⁵ M⁻¹ s⁻¹ and koff = 0.001 s⁻¹ give KD = 10 nM. Increasing both rates tenfold gives the same KD. | \nThe corresponding dissociation half-times are about 693 and 69 seconds. These are simple-model calculations; cellular occupancy also depends on exposure, transport and the biological system. | \nChoose an instrument and protocol able to resolve the rates that distinguish the candidates. Report association and dissociation rates with the affinity when they are identifiable. Equal KD values do not make two compounds interchangeable for a time-dependent biological experiment. Constructed kinetic calculation; no prediction of cellular residence time. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Biacore 8S and 8S+ emphasize parallel flow-based analysis. SPR CONFIGURATION | \nCytiva's May 2026 guide lists 16 flow cells in eight channels for both models. Sample capacity is four 96- or 384-well plates for 8S and twelve for 8S+. The 8S and older 8K generations must retain their own specifications. | \nFlow cells include reference roles; their count is not a count of independently interpretable target interactions. Plate capacity does not determine how many complete concentration series finish in a day. | \nConsider this family for substantial screening and characterization workloads that justify parallel fluidics. Demonstrate the intended referencing scheme, regeneration and control frequency. Ask for completed, accepted kinetic results per day under that method. Sources: B1. PDF p 4; manufacturer configuration data. | \n
Octet RH16 measures up to sixteen biosensors in parallel. BLI CONFIGURATION | \nThe RH16 datasheet lists 16 spectrometers, up to 16 simultaneous reads and two plate positions. Supported formats include standard 96- and 384-well plates and the specified 384 tilted-well plate. | \nSensors, reference wells and concentration-series design determine usable experimental parallelism. A full set of probes does not necessarily represent sixteen different compounds with complete kinetic characterization. | \nBLI is attractive when a dip-and-read workflow fits the sample set, including protein screening and characterization. Map the entire experiment onto sensors and wells before estimating throughput. Reserve capacity for blanks, controls and failed or unsuitable surfaces. Sources: B3. PDF p 4; manufacturer configuration data. | \n
WAVE and WAVEdelta differ in more than their names. GCI CONFIGURATION | \nThe brochure lists two parallel flow paths for WAVE and four for WAVEdelta. WAVEdelta adds flexible channel referencing, switching among four buffers and waveRAPID functionality; the listed WAVE model does not provide waveRAPID. | \nA result produced with one configuration should not be used to promise the other's throughput or method options. Reference allocation further reduces the number of simultaneous target measurements. | \nFor a GCI demonstration, specify the actual model, fluidic arrangement, software and method. Compare conventional concentration-series kinetics with the accelerated method where available, using the same target and a representative set of analytes. Sources: B6. PDF p 7, printed pp 12–13; model-specific features. | \n
Required sample volume and consumed sample are different quantities. MATERIAL BUDGET | \nRH16 lists 40–100 µL per well in its tilted-well format, 80–130 µL in standard 384-well plates and 180–220 µL in 96-well plates. Biacore 8S lists injection volume plus an application-dependent 20–50 µL. | \nA BLI well may permit sample recovery, but recovered material has experienced contact and incubation. Flow-based sample requirements include access volume beyond the liquid injected over the surface. | \nBudget the mass needed for the complete concentration series, references, replicates and repeat runs. Specify what can genuinely be recovered and reused. Small disposable sensors and small sensor chambers do not by themselves establish low total sample consumption. Sources: B3, B1. Manufacturer volumes; practical material accounting. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Stable temperature is part of the kinetic experiment. THERMAL CONTROL | \nBiacore 8S lists 4–40°C under its stated ambient conditions; RH16 specifies ambient plus 4°C to 40°C. WAVE lists 15–40°C and WAVEdelta 4–45°C, with a maximum 15°C depression below ambient for WAVEdelta. | \nThe room-temperature label does not establish a common measurement temperature. If a laboratory is 24°C, an ambient-plus-4°C lower limit corresponds to 28°C. Sample storage temperature is another setting. | \nChoose a temperature supported by all systems in a cross-platform study, then equilibrate buffers, samples and surfaces. If the scientific question requires a temperature one configuration cannot hold, treat that as a real selection constraint. Use a temperature appropriate to the interaction and hold it reproducibly. Sources: B1, B2, B6. Conditional specifications and arithmetic example. | \n
A faster optical readout does not establish faster resolvable kinetics. TIME RESOLUTION | \nAssociation and dissociation are observed after sample delivery changes the local analyte concentration. Fluid exchange, dispersion and the instrument's acquisition interval all contribute to the observed transition. | \nA nominal sampling frequency can be much faster than the effective concentration step. Fitting an interaction that disappears largely during the transition can produce a precise-looking but poorly constrained rate. | \nChallenge the intended fast-rate regime using a suitable reference interaction. Inspect the injection transition and residuals, not only the fitted parameter. Require the vendor to explain the validated rate range for that molecular class, surface and acquisition method. Sources: B4, B7. Mechanistic inference and proposed time-response test. | \n
Accelerated methods change the experimental design. WAVERAPID | \nThe manufacturer describes waveRAPID as repeated analyte pulses of increasing duration at one concentration. Its hit-discovery study compares this approach with conventional kinetic measurements for the tested compounds. | \nOne concentration reduces preparation work but retains dependence on concentration accuracy, model suitability and enough information in the pulse response. Results from the published set do not establish universal equivalence. | \nUse it for a representative screening challenge, then confirm important or unusual hits with a concentration series and appropriate controls. Retain the raw response and method settings. Faster triage has value when its errors are understood and consequential hits receive suitable follow-up. Sources: B7. Manufacturer study and proposed confirmation strategy. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Small molecules demand an honest signal budget. FRAGMENT AND COMPOUND WORK | \nSartorius provides a small-molecule kinetics protocol for appropriate Octet configurations. Such measurements require deliberate target loading, controls and assay optimization; BLI is not categorically restricted to large analytes. | \nLow molecular mass produces a small binding response relative to the immobilized target. Raising surface loading can increase response while worsening surface-related artifacts. Solubility and stock solvent can constrain attainable concentrations. | \nBring representative low-mass compounds, weak binders and negatives to the demonstration. Ask for acceptable kinetic results at realistic concentrations. Avoid selecting from a molecular-weight limit alone, or extrapolating an antibody demonstration to a fragment campaign. Sources: B5. Application-specific capability and proposed test. | \n
Surface density is an experimental variable. IMMOBILIZATION | \nZhao and colleagues compared SPR surface chemistries, loading densities and capture strategies in an antibody–antigen model. Their study examines changes in activity and heterogeneity as well as fitted binding parameters. | \nMore immobilized protein can create a larger signal without preserving the same accessible population. Coupling orientation or local crowding can change which sites the analyte encounters. | \nPrepare at least two useful surface densities, and consider another capture orientation for consequential results. Seek rates that remain reasonably consistent when the experiment is changed in ways that should preserve the molecular interaction. Treat reproducibility on one surface as incomplete evidence. Sources: B9. Primary study; proposed discrimination test. | \n
Transport and rebinding can imitate slow molecular behavior. KINETIC ARTIFACTS | \nSartorius' kinetics guide discusses transport-limited association and analyte rebinding. Delivery to a crowded surface can limit observed association; dissociated analyte can encounter another nearby binding site. | \nIncreasing flow or agitation and reducing ligand loading may change these effects, but the intervention must remain compatible with the assay. Adding fit parameters alone does not identify the correct mechanism. | \nCompare reasonable flow or agitation settings and loading densities. Inspect whether the derived rates move systematically. If they do, investigate transport and surface behavior before interpreting an unusually slow dissociation as a desirable compound property. Sources: B4. Mechanistic guidance and proposed controls. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Avidity can make a multivalent analyte look exceptionally tight. BIOLOGICS | \nThe Octet avidity guidance identifies assay orientation, valency, ligand density and nonspecific binding as important design variables. A multivalent analyte may maintain attachment through more than one interaction. | \nAn apparent slow off-rate can describe that multivalent configuration rather than a single binding site's intrinsic affinity. A one-to-one fit may conceal the distinction while producing attractive numbers. | \nUse a monovalent reagent or reverse the orientation when feasible, and vary surface density. Decide whether the program needs intrinsic affinity or functional avidity in a defined geometry. Both can be useful, provided the reported quantity matches the experiment. Sources: B8. Manufacturer assay-design guidance and interpretation. | \n
Solvent and matrix effects deserve their own references. BACKGROUND RESPONSE | \nThe Octet small-molecule note addresses preparation and control of DMSO-containing measurements. Surface-based optical signals can also respond to nonspecific material and differences between sample and running buffer. | \nSubtracting a reference can remove shared response while leaving mismatches between surfaces. A target-free surface may not reproduce the nonspecific binding of a protein-coated surface. | \nMatch solvent composition, inspect blanks across the concentration range and use the platform's validated referencing or solvent-correction procedure. Examine unprocessed curves alongside corrected data. A correction that leaves a tidy curve has not, by itself, established target-specific binding. Sources: B5. Source-supported controls; interpretation applies within the chosen platform method. | \n
Very slow dissociation needs enough time to be observed. IDENTIFIABILITY | \nFor a constructed first-order koff of 10⁻⁶ s⁻¹, the half-time is about eight days. During a ten-minute dissociation interval, the ideal signal falls by only 0.060%. | \nDrift, regeneration effects and surface stability can overwhelm that small change. A lower advertised rate limit does not mean every short run can determine a rate at that limit. | \nDesign observation time around the change that must be distinguished from baseline behavior. Report a bound or an unresolved slow rate when the data do not identify a precise value. Avoid turning a flat trace into an exact residence-time claim. Constructed exponential-decay calculation. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Parallel BLI can simplify protein screening logistics. WORKFLOW FIT | \nThe RH16's parallel probe format and plate handling can suit repeated measurements across protein samples. Sample contact occurs at disposable biosensor tips rather than requiring every sample to traverse a shared sensing flow cell. | \nSensor preparation, well volume, incubation time and reference allocation still consume capacity. Matrix tolerance must be shown for the actual samples and detection surface. | \nFavor this approach when the plate-based preparation and analysis workflow match the program. Demonstrate crude and purified samples separately. Include the cost of sensor loading and repeat measurements when comparing it with flow-based methods. Sources: B3. Configuration-based recommendation; no universal superiority claim. | \n
Flow control can support discriminating kinetic experiments. WORKFLOW FIT | \nBiacore and WAVEsystem configurations provide controlled fluid delivery over sensor surfaces. Changing delivery conditions can help probe whether observed behavior is limited by transport or by the interaction itself. | \nFlow paths require suitable samples, cleaning and carryover control. A disposable sensing cartridge can simplify part of that handling while leaving autosampler and upstream sample-contact components to consider. | \nFavor a flow-based approach when the question benefits from defined injections, rapid buffer changes or delivery-rate challenges. Use a difficult but realistic sample sequence to assess carryover, recovery and maintenance time. Evaluate data quality after that challenge, not just during a clean reference run. | \n
Independent methods can expose a shared-looking result. ORTHOGONAL CONFIRMATION | \nA solution-phase binding or functional assay can ask a different question from a surface measurement. Agreement is particularly useful when the experimental dependencies are genuinely different. | \nChanging the optical detector while retaining the same construct, capture reagent and immobilization geometry may preserve the dominant artifact. Disagreement can also arise from temperature, valency or buffer changes rather than instrument failure. | \nFor important candidates, document what changed between methods. Reconcile differences by testing the most plausible cause. Choose confirmation experiments that distinguish the competing explanations. Another KD becomes useful when its experimental dependencies are understood. Proposed confirmation strategy. | \n
| The finding | Technology and product evidence | Trade-offs and controls | What it means |
|---|---|---|---|
Request the raw curves and a challenge set. DEMONSTRATION | \nProvide a reference binder, a negative, a weak binder, a fast interaction and a sample with realistic matrix complexity. Predefine the concentrations, observation periods and referencing rules before comparing systems. | \nA vendor's best example leaves the success rate for a mixed discovery sample set unresolved. Retain failed fits and low-response samples in that denominator. | \nCount accepted results, unresolved rates, repeats and material used. Review residuals, reference traces and fit exclusions with the vendor. Keep temperature and biological materials aligned where possible, and explicitly record unavoidable differences between methods. Proposed benchmark; no physical cross-platform test performed. | \n
Buy the supported method as well as the instrument. CORE LAB AND PROGRAM FIT | \nThe operating cost includes sensor consumables, coupling reagents, sample preparation, cleaning, analysis software, staff training and time spent resolving difficult curves. Prices and support packages require current quotations. | \nAn instrument may cover many applications in principle while local expertise supports only a few robustly. Automated fitting can reduce routine work without replacing someone who recognizes a failed model. | \nFor a core facility, assess changeover and training across targets. For a screening program, assess accepted results from the recurring method. Include a written acceptance experiment and access to raw data in the purchasing discussion. Procurement and staffing recommendation. | \n
Manufacturer specifications describe the named product and configuration; they are not independent all-vendor benchmarks. Row-level source IDs link to the references below. Calculations and practical interpretations are identified separately. No physical comparison or procurement quotation is represented by these tables.
" }, { "type": "p", "text": "B1 Cytiva Biacore selection guide May 2026", "html": "B1 Cytiva Biacore selection guide May 2026
" }, { "type": "p", "text": "B2 Octet RH16 specifications", "html": "" }, { "type": "p", "text": "B3 Octet RH16 datasheet", "html": "" }, { "type": "p", "text": "B4 Octet binding kinetics application note", "html": "B4 Octet binding kinetics application note
" }, { "type": "p", "text": "B5 Octet small molecule binding kinetics", "html": "B5 Octet small molecule binding kinetics
" }, { "type": "p", "text": "B6 WAVEsystem brochure", "html": "" }, { "type": "p", "text": "B7 waveRAPID hit discovery study", "html": "B7 waveRAPID hit discovery study
" }, { "type": "p", "text": "B8 Octet avoiding avidity", "html": "" }, { "type": "p", "text": "B9 Zhao et al 2013 — A comparison of binding surfaces for SPR biosensing, abstract and figure captions", "html": "B9 Zhao et al 2013 — A comparison of binding surfaces for SPR biosensing, abstract and figure captions
" } ] } ], "references": [ { "id": "ref-b1", "citation": "B1 Cytiva Biacore selection guide May 2026", "urls": [ "https://cdn.cytivalifesciences.com/api/public/content/digi-32607-original" ] }, { "id": "ref-b2", "citation": "B2 Octet RH16 specifications", "urls": [ "https://www.sartorius.com/en/products/biolayer-interferometry/octet-rh16" ] }, { "id": "ref-b3", "citation": "B3 Octet RH16 datasheet", "urls": [ "https://www.sartorius.com/download/775202/octet-red384-system-datasheet-en-sartorius-data.pdf" ] }, { "id": "ref-b4", "citation": "B4 Octet binding kinetics application note", "urls": [ "https://www.sartorius.com/resource/blob/742330/05671fe2de45d16bd72b8078ac28980d/octet-biomolecular-binding-kinetics-application-note-4014-en-1-data.pdf" ] }, { "id": "ref-b5", "citation": "B5 Octet small molecule binding kinetics", "urls": [ "https://www.sartorius.com/download/1291550/octet-small-molecule-binding-kinetics-tech-note-en-l-sartori-1--data.pdf" ] }, { "id": "ref-b6", "citation": "B6 WAVEsystem brochure", "urls": [ "https://www.malvernpanalytical.com/es/assets/malvern_panalytical_wavesystem_brochure_pn13518_tcm61-96078.pdf" ] }, { "id": "ref-b7", "citation": "B7 waveRAPID hit discovery study", "urls": [ "https://www.malvernpanalytical.com/en/learn/knowledge-center/technical-notes/tn201001-hit-discovery-novel-kinetic-assay" ] }, { "id": "ref-b8", "citation": "B8 Octet avoiding avidity", "urls": [ "https://www.sartorius.com/en/products/biolayer-interferometry/bli-resources/optimizing-kinetics-assays-to-avoid-avidity-application-note" ] }, { "id": "ref-b9", "citation": "B9 Zhao et al 2013 — A comparison of binding surfaces for SPR biosensing, abstract and figure captions", "urls": [ "https://pubmed.ncbi.nlm.nih.gov/23270815/" ] } ], "equations": [], "tables": [ { "caption": "Label free binding instruments for drug discovery — Headlines", "rows": [ [ "The finding", "Technology and product evidence", "Trade-offs and controls", "What it means" ], [ "All three observe binding near an immobilized surface.MEASUREMENT PRINCIPLE", "SPR detects an optical response near a sensor surface; BLI follows interference changes at a biosensor tip; GCI detects refractive-index changes along a waveguide. Binding accumulates material in the sensing region.", "Specific binding, nonspecific adsorption and some solution changes can all contribute. Removing a fluorescent label removes one experimental dependency while retaining surface preparation and reference requirements.", "Begin with a binding-positive control, a negative analyte and a suitable reference surface. Establish which part of the response is attributable to the intended interaction before choosing a kinetic model. Inspect the reference response before trusting the corrected binding trace.Sources: B1, B4, B6. Mechanistic comparison and proposed controls." ], [ "Affinity alone can conceal very different residence times.KINETIC INTERPRETATION", "For an ideal one-to-one interaction, KD = koff/kon. In a constructed example, kon = 10⁵ M⁻¹ s⁻¹ and koff = 0.001 s⁻¹ give KD = 10 nM. Increasing both rates tenfold gives the same KD.", "The corresponding dissociation half-times are about 693 and 69 seconds. These are simple-model calculations; cellular occupancy also depends on exposure, transport and the biological system.", "Choose an instrument and protocol able to resolve the rates that distinguish the candidates. Report association and dissociation rates with the affinity when they are identifiable. Equal KD values do not make two compounds interchangeable for a time-dependent biological experiment.Constructed kinetic calculation; no prediction of cellular residence time." ] ], "data_kind": "source comparison and stated illustrative calculations" }, { "caption": "Label free binding instruments for drug discovery — Specifications", "rows": [ [ "The finding", "Technology and product evidence", "Trade-offs and controls", "What it means" ], [ "Biacore 8S and 8S+ emphasize parallel flow-based analysis.SPR CONFIGURATION", "Cytiva's May 2026 guide lists 16 flow cells in eight channels for both models. Sample capacity is four 96- or 384-well plates for 8S and twelve for 8S+. The 8S and older 8K generations must retain their own specifications.", "Flow cells include reference roles; their count is not a count of independently interpretable target interactions. Plate capacity does not determine how many complete concentration series finish in a day.", "Consider this family for substantial screening and characterization workloads that justify parallel fluidics. Demonstrate the intended referencing scheme, regeneration and control frequency. Ask for completed, accepted kinetic results per day under that method.Sources: B1. PDF p 4; manufacturer configuration data." ], [ "Octet RH16 measures up to sixteen biosensors in parallel.BLI CONFIGURATION", "The RH16 datasheet lists 16 spectrometers, up to 16 simultaneous reads and two plate positions. Supported formats include standard 96- and 384-well plates and the specified 384 tilted-well plate.", "Sensors, reference wells and concentration-series design determine usable experimental parallelism. A full set of probes does not necessarily represent sixteen different compounds with complete kinetic characterization.", "BLI is attractive when a dip-and-read workflow fits the sample set, including protein screening and characterization. Map the entire experiment onto sensors and wells before estimating throughput. Reserve capacity for blanks, controls and failed or unsuitable surfaces.Sources: B3. PDF p 4; manufacturer configuration data." ], [ "WAVE and WAVEdelta differ in more than their names.GCI CONFIGURATION", "The brochure lists two parallel flow paths for WAVE and four for WAVEdelta. WAVEdelta adds flexible channel referencing, switching among four buffers and waveRAPID functionality; the listed WAVE model does not provide waveRAPID.", "A result produced with one configuration should not be used to promise the other's throughput or method options. Reference allocation further reduces the number of simultaneous target measurements.", "For a GCI demonstration, specify the actual model, fluidic arrangement, software and method. Compare conventional concentration-series kinetics with the accelerated method where available, using the same target and a representative set of analytes.Sources: B6. PDF p 7, printed pp 12–13; model-specific features." ], [ "Required sample volume and consumed sample are different quantities.MATERIAL BUDGET", "RH16 lists 40–100 µL per well in its tilted-well format, 80–130 µL in standard 384-well plates and 180–220 µL in 96-well plates. Biacore 8S lists injection volume plus an application-dependent 20–50 µL.", "A BLI well may permit sample recovery, but recovered material has experienced contact and incubation. Flow-based sample requirements include access volume beyond the liquid injected over the surface.", "Budget the mass needed for the complete concentration series, references, replicates and repeat runs. Specify what can genuinely be recovered and reused. Small disposable sensors and small sensor chambers do not by themselves establish low total sample consumption.Sources: B3, B1. Manufacturer volumes; practical material accounting." ] ], "data_kind": "source comparison and stated illustrative calculations" }, { "caption": "Label free binding instruments for drug discovery — Features", "rows": [ [ "The finding", "Technology and product evidence", "Trade-offs and controls", "What it means" ], [ "Stable temperature is part of the kinetic experiment.THERMAL CONTROL", "Biacore 8S lists 4–40°C under its stated ambient conditions; RH16 specifies ambient plus 4°C to 40°C. WAVE lists 15–40°C and WAVEdelta 4–45°C, with a maximum 15°C depression below ambient for WAVEdelta.", "The room-temperature label does not establish a common measurement temperature. If a laboratory is 24°C, an ambient-plus-4°C lower limit corresponds to 28°C. Sample storage temperature is another setting.", "Choose a temperature supported by all systems in a cross-platform study, then equilibrate buffers, samples and surfaces. If the scientific question requires a temperature one configuration cannot hold, treat that as a real selection constraint. Use a temperature appropriate to the interaction and hold it reproducibly.Sources: B1, B2, B6. Conditional specifications and arithmetic example." ], [ "A faster optical readout does not establish faster resolvable kinetics.TIME RESOLUTION", "Association and dissociation are observed after sample delivery changes the local analyte concentration. Fluid exchange, dispersion and the instrument's acquisition interval all contribute to the observed transition.", "A nominal sampling frequency can be much faster than the effective concentration step. Fitting an interaction that disappears largely during the transition can produce a precise-looking but poorly constrained rate.", "Challenge the intended fast-rate regime using a suitable reference interaction. Inspect the injection transition and residuals, not only the fitted parameter. Require the vendor to explain the validated rate range for that molecular class, surface and acquisition method.Sources: B4, B7. Mechanistic inference and proposed time-response test." ], [ "Accelerated methods change the experimental design.WAVERAPID", "The manufacturer describes waveRAPID as repeated analyte pulses of increasing duration at one concentration. Its hit-discovery study compares this approach with conventional kinetic measurements for the tested compounds.", "One concentration reduces preparation work but retains dependence on concentration accuracy, model suitability and enough information in the pulse response. Results from the published set do not establish universal equivalence.", "Use it for a representative screening challenge, then confirm important or unusual hits with a concentration series and appropriate controls. Retain the raw response and method settings. Faster triage has value when its errors are understood and consequential hits receive suitable follow-up.Sources: B7. Manufacturer study and proposed confirmation strategy." ] ], "data_kind": "source comparison and stated illustrative calculations" }, { "caption": "Label free binding instruments for drug discovery — Capabilities", "rows": [ [ "The finding", "Technology and product evidence", "Trade-offs and controls", "What it means" ], [ "Small molecules demand an honest signal budget.FRAGMENT AND COMPOUND WORK", "Sartorius provides a small-molecule kinetics protocol for appropriate Octet configurations. Such measurements require deliberate target loading, controls and assay optimization; BLI is not categorically restricted to large analytes.", "Low molecular mass produces a small binding response relative to the immobilized target. Raising surface loading can increase response while worsening surface-related artifacts. Solubility and stock solvent can constrain attainable concentrations.", "Bring representative low-mass compounds, weak binders and negatives to the demonstration. Ask for acceptable kinetic results at realistic concentrations. Avoid selecting from a molecular-weight limit alone, or extrapolating an antibody demonstration to a fragment campaign.Sources: B5. Application-specific capability and proposed test." ], [ "Surface density is an experimental variable.IMMOBILIZATION", "Zhao and colleagues compared SPR surface chemistries, loading densities and capture strategies in an antibody–antigen model. Their study examines changes in activity and heterogeneity as well as fitted binding parameters.", "More immobilized protein can create a larger signal without preserving the same accessible population. Coupling orientation or local crowding can change which sites the analyte encounters.", "Prepare at least two useful surface densities, and consider another capture orientation for consequential results. Seek rates that remain reasonably consistent when the experiment is changed in ways that should preserve the molecular interaction. Treat reproducibility on one surface as incomplete evidence.Sources: B9. Primary study; proposed discrimination test." ], [ "Transport and rebinding can imitate slow molecular behavior.KINETIC ARTIFACTS", "Sartorius' kinetics guide discusses transport-limited association and analyte rebinding. Delivery to a crowded surface can limit observed association; dissociated analyte can encounter another nearby binding site.", "Increasing flow or agitation and reducing ligand loading may change these effects, but the intervention must remain compatible with the assay. Adding fit parameters alone does not identify the correct mechanism.", "Compare reasonable flow or agitation settings and loading densities. Inspect whether the derived rates move systematically. If they do, investigate transport and surface behavior before interpreting an unusually slow dissociation as a desirable compound property.Sources: B4. Mechanistic guidance and proposed controls." ] ], "data_kind": "source comparison and stated illustrative calculations" }, { "caption": "Label free binding instruments for drug discovery — Downsides", "rows": [ [ "The finding", "Technology and product evidence", "Trade-offs and controls", "What it means" ], [ "Avidity can make a multivalent analyte look exceptionally tight.BIOLOGICS", "The Octet avidity guidance identifies assay orientation, valency, ligand density and nonspecific binding as important design variables. A multivalent analyte may maintain attachment through more than one interaction.", "An apparent slow off-rate can describe that multivalent configuration rather than a single binding site's intrinsic affinity. A one-to-one fit may conceal the distinction while producing attractive numbers.", "Use a monovalent reagent or reverse the orientation when feasible, and vary surface density. Decide whether the program needs intrinsic affinity or functional avidity in a defined geometry. Both can be useful, provided the reported quantity matches the experiment.Sources: B8. Manufacturer assay-design guidance and interpretation." ], [ "Solvent and matrix effects deserve their own references.BACKGROUND RESPONSE", "The Octet small-molecule note addresses preparation and control of DMSO-containing measurements. Surface-based optical signals can also respond to nonspecific material and differences between sample and running buffer.", "Subtracting a reference can remove shared response while leaving mismatches between surfaces. A target-free surface may not reproduce the nonspecific binding of a protein-coated surface.", "Match solvent composition, inspect blanks across the concentration range and use the platform's validated referencing or solvent-correction procedure. Examine unprocessed curves alongside corrected data. A correction that leaves a tidy curve has not, by itself, established target-specific binding.Sources: B5. Source-supported controls; interpretation applies within the chosen platform method." ], [ "Very slow dissociation needs enough time to be observed.IDENTIFIABILITY", "For a constructed first-order koff of 10⁻⁶ s⁻¹, the half-time is about eight days. During a ten-minute dissociation interval, the ideal signal falls by only 0.060%.", "Drift, regeneration effects and surface stability can overwhelm that small change. A lower advertised rate limit does not mean every short run can determine a rate at that limit.", "Design observation time around the change that must be distinguished from baseline behavior. Report a bound or an unresolved slow rate when the data do not identify a precise value. Avoid turning a flat trace into an exact residence-time claim.Constructed exponential-decay calculation." ] ], "data_kind": "source comparison and stated illustrative calculations" }, { "caption": "Label free binding instruments for drug discovery — Advantages", "rows": [ [ "The finding", "Technology and product evidence", "Trade-offs and controls", "What it means" ], [ "Parallel BLI can simplify protein screening logistics.WORKFLOW FIT", "The RH16's parallel probe format and plate handling can suit repeated measurements across protein samples. Sample contact occurs at disposable biosensor tips rather than requiring every sample to traverse a shared sensing flow cell.", "Sensor preparation, well volume, incubation time and reference allocation still consume capacity. Matrix tolerance must be shown for the actual samples and detection surface.", "Favor this approach when the plate-based preparation and analysis workflow match the program. Demonstrate crude and purified samples separately. Include the cost of sensor loading and repeat measurements when comparing it with flow-based methods.Sources: B3. Configuration-based recommendation; no universal superiority claim." ], [ "Flow control can support discriminating kinetic experiments.WORKFLOW FIT", "Biacore and WAVEsystem configurations provide controlled fluid delivery over sensor surfaces. Changing delivery conditions can help probe whether observed behavior is limited by transport or by the interaction itself.", "Flow paths require suitable samples, cleaning and carryover control. A disposable sensing cartridge can simplify part of that handling while leaving autosampler and upstream sample-contact components to consider.", "Favor a flow-based approach when the question benefits from defined injections, rapid buffer changes or delivery-rate challenges. Use a difficult but realistic sample sequence to assess carryover, recovery and maintenance time. Evaluate data quality after that challenge, not just during a clean reference run.Sources: B1, B6. Mechanistic and workflow inference." ], [ "Independent methods can expose a shared-looking result.ORTHOGONAL CONFIRMATION", "A solution-phase binding or functional assay can ask a different question from a surface measurement. Agreement is particularly useful when the experimental dependencies are genuinely different.", "Changing the optical detector while retaining the same construct, capture reagent and immobilization geometry may preserve the dominant artifact. Disagreement can also arise from temperature, valency or buffer changes rather than instrument failure.", "For important candidates, document what changed between methods. Reconcile differences by testing the most plausible cause. Choose confirmation experiments that distinguish the competing explanations. Another KD becomes useful when its experimental dependencies are understood.Proposed confirmation strategy." ] ], "data_kind": "source comparison and stated illustrative calculations" }, { "caption": "Label free binding instruments for drug discovery — Notable Details", "rows": [ [ "The finding", "Technology and product evidence", "Trade-offs and controls", "What it means" ], [ "Request the raw curves and a challenge set.DEMONSTRATION", "Provide a reference binder, a negative, a weak binder, a fast interaction and a sample with realistic matrix complexity. Predefine the concentrations, observation periods and referencing rules before comparing systems.", "A vendor's best example leaves the success rate for a mixed discovery sample set unresolved. Retain failed fits and low-response samples in that denominator.", "Count accepted results, unresolved rates, repeats and material used. Review residuals, reference traces and fit exclusions with the vendor. Keep temperature and biological materials aligned where possible, and explicitly record unavoidable differences between methods.Proposed benchmark; no physical cross-platform test performed." ], [ "Buy the supported method as well as the instrument.CORE LAB AND PROGRAM FIT", "The operating cost includes sensor consumables, coupling reagents, sample preparation, cleaning, analysis software, staff training and time spent resolving difficult curves. Prices and support packages require current quotations.", "An instrument may cover many applications in principle while local expertise supports only a few robustly. Automated fitting can reduce routine work without replacing someone who recognizes a failed model.", "For a core facility, assess changeover and training across targets. For a screening program, assess accepted results from the recurring method. Include a written acceptance experiment and access to raw data in the purchasing discussion.Procurement and staffing recommendation." ] ], "data_kind": "source comparison and stated illustrative calculations" } ], "display_additions": {}, "content_sha256": "a7e79d64fdb703af3d6751387b13c3bc884a61b71aa9433391d87fe7917a06db" }